Background: Although pleurodesis is an effective treatment for malignant pleural effusion, we hesitate to use in patients with poor performance status (PS) because of its side effects.
Methods: Of 46 pleurodesis cases in our institution between 2006 and 2010, 24 poor PS cases (>3) were classified into 2 groups according to survival (beyond 3 months) or non-survival, and 3 groups according to condition: PS improved after pleurodesis, remained stable, or was exacerbated and we analyzed their backgrounds.
Results: Among the 24 cases (66.7%), there were 5 and 19 survival and non-survival cases. Patient backgrounds, characteristics of the lesions and examination results did not differ significantly among them. On the other hand, the ratio of successful initial pleurodesis in the exacerbated PS group was lower than in the improved and stable groups (16.7% vs. 100%, 87.5%). The 1- and 3-month survival rates of unsuccessful cases were lower than those of successful cases (33.3% vs. 77.8%, 0% vs. 32.4%).
Conclusion: Success of initial pleurodesis can affect PS and outcome, thus it is important to improve the number of successful cases of initial pleurodesis.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Endobronchial Valve Insertion for the Management of Persistent Air Leak Following Pneumothorax.
Cureus
November 2024
Respiratory Medicine, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, GBR.
Persistent air leak following a pneumothorax refers to air leakage lasting 5-7 days after the initial event. Different strategies have been used with varying degrees of success including surgical or chemical pleurodesis. Endobronchial valve (EBV) insertion is a technique where the insertion of a one-way valve obstructs the flow of air through the leak and helps in pneumothorax resolution especially if surgery is contraindicated.
View Article and Find Full Text PDFLenvatinib treatment strategy for thyroid carcinoma with malignant pleurisy: a case report.
Gland Surg
October 2024
Department of Thoracic, Endocrine Surgery and Oncology, Institute of Health, Biosciences, The University of Tokushima, Tokushima, Japan.
Background: Although lenvatinib is effective for unresectable thyroid carcinoma, it may cause adverse events owing to rapid tumor shrinkage or necrosis. Pneumothorax during lenvatinib therapy is rare. However, once it occurs, it can become a refractory and fatal complication.
View Article and Find Full Text PDFIs chest tube omission safe for patients with primary spontaneous pneumothorax scheduled for video-assisted thoracoscopic surgery?
Ann Thorac Med
October 2024
Department of Thoracic and Cardiovascular Surgery, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju-Si, South Korea.
Article Synopsis
- - The study explores the necessity of chest tube insertion before surgery for primary spontaneous pneumothorax (PSP) in young patients, finding it may not be needed.
- - Researchers analyzed records of 128 patients aged 14-30 who underwent video-assisted thoracoscopic surgery (VATS) and compared outcomes between those who had chest tubes and those who didn’t.
- - Results showed no major differences in complication rates or recovery between the two groups, but the non-chest tube group enjoyed a shorter hospital stay and a higher rate of single-port surgeries.
Mortality after treatment of malignant pleural effusions with indwelling pleural catheters versus chemical pleurodesis: a population-based study.
Respir Res
November 2024
Department of Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
Background: Little is known about patient outcomes following treatment of malignant pleural effusions (MPE) in the real-world setting.
Research Question: We aimed to compare post-procedure all-cause mortality between individuals who received indwelling pleural catheter (IPC) insertion versus chemical pleurodesis for managing MPEs.
Study Design And Methods: We performed a retrospective population-based study using provincial health administrative data (Ontario, Canada) of adults with a MPE who underwent IPC insertion or chemical pleurodesis between 2015 and 2019.
Chest Tubes and Pleural Drainage: History and Current Status in Pleural Disease Management.
J Clin Med
October 2024
Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
Article Synopsis
- Thoracostomy and chest tube placement are essential procedures for managing pleural diseases caused by fluid or air buildup in the pleural cavity, with historic methods evolving significantly since Hippocrates.
- The development of closed drainage systems in the 19th century and advancements in materials, such as plastic and the Heimlich valve, have improved chest tube designs and functionality.
- Modern techniques include various tube designs, digital monitoring systems, and the use of pleurodesis to prevent complications, ensuring that chest tube insertion continues to play a vital role in treating pleural conditions effectively.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!